Area of research
Molecular Biology · Epidemiology
Research interest
Research interests include Medicine, Metabolomics, Ovarian cancer, Biomarker, Computational biology, and Internal medicine.
Privacy Protection for Open Sharing of Psychiatric and Behavioral Research Data: Ethical Considerations and Recommendations
Association between the proportions of carbohydrate and fat intake and hypertension risk: findings from the China Health and Nutrition Survey
Association between Dietary Quality and Prediabetes based on the Diet Balance Index
Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery
Author Correction: Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis
Large-scale Metabolomic Analysis Reveals Potential Biomarkers for Early Stage Coronary Atherosclerosis
Metabolic phenotyping for monitoring ovarian cancer patients
Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer
Exhaled breath volatile biomarker analysis for thyroid cancer
Plasma Metabolic Profiles in Women are Menopause Dependent
Differential plasma lipids profiling and lipid signatures as biomarkers in the early diagnosis of ovarian carcinoma using UPLC-MS
Large‐scale profiling of metabolic dysregulation in ovarian cancer
Noninvasive detection of colorectal cancer by analysis of exhaled breath
Exhaled volatile organic compounds as lung cancer biomarkers during one-lung ventilation
Volatile Organic Metabolites Identify Patients with Breast Cancer, Cyclomastopathy and Mammary Gland Fibroma
Prediction of advanced ovarian cancer recurrence by plasma metabolic profiling
Blood Volatile Organic Compounds as Potential Biomarkers for Amyotrophic Lateral Sclerosis: an Animal Study in the SOD1 G93A Mouse
Blood volatile compounds as biomarkers for colorectal cancer
Identification of biomarkers for unstable angina by plasma metabolomic profiling
Identification of Potential Biomarkers for Ovarian Cancer by Urinary Metabolomic Profiling
Discrimination between malignant and benign ovarian tumors by plasma metabolomic profiling using ultra performance liquid chromatography/mass spectrometry